Nicotine Gum Sales

Nicotine Gum Sales Market Outlook

The global nicotine gum market is anticipated to reach approximately USD 3.5 billion by 2035, with a compound annual growth rate (CAGR) of around 6.1% during the forecast period from 2025 to 2035. This growth is primarily driven by the rising prevalence of smoking-related health issues and an increasing number of smokers seeking effective cessation aids. The growing acceptance of nicotine gums as a viable alternative to traditional smoking methods, coupled with heightened awareness regarding the health risks associated with tobacco consumption, is further propelling market expansion. Additionally, favorable government initiatives and investments aimed at promoting smoking cessation strategies contribute significantly to the growth of the nicotine gum market. Innovations in product formulations, such as flavored gums and varying nicotine concentrations, have also heightened consumer interest and adoption.

Growth Factor of the Market

One of the primary growth factors for the nicotine gum market is the increasing health awareness among individuals regarding the dangers of smoking and the benefits of cessation products. As more smokers seek to quit or reduce their tobacco consumption, they are turning to alternatives like nicotine gum, which provides a controlled dose of nicotine without the harmful effects associated with smoking. Furthermore, the surge in the number of smoking cessation programs and initiatives across various health organizations and governments worldwide has created a supportive environment for the nicotine gum market to flourish. The convenience of over-the-counter availability, coupled with the ability for consumers to use nicotine gum discreetly, is also influencing purchasing decisions. The rising trend of e-commerce has made nicotine gum more accessible than ever, allowing consumers to purchase products from the comfort of their homes. Additionally, as public spaces increasingly become smoke-free, nicotine gum has emerged as a preferred choice for many individuals looking to manage their cravings in social settings.

Key Highlights of the Market

• Projected market size of USD 3.5 billion by 2035, growing at a CAGR of 6.1%.
• Rise in health awareness driving the adoption of nicotine gums for smoking cessation.
• Increased accessibility through online retail and pharmacies.
• Product innovation with varied flavors and nicotine concentrations.
• Supportive government initiatives promoting smoking cessation.

By Product Type

2mg Nicotine Gum:

The 2mg nicotine gum segment is a popular choice among lighter smokers or those who are just starting their journey to quit smoking. This variant is designed for individuals who smoke fewer than 25 cigarettes a day. The lower nicotine content helps to reduce withdrawal symptoms without overwhelming the user, making it an effective tool for smoking cessation and nicotine replacement therapy. The 2mg gum is often favored for its milder impact, allowing users to control their nicotine intake gradually. Its popularity is further enhanced by the availability of diverse flavors, which makes it more palatable to consumers, thus encouraging adherence to the quitting process. As healthcare professionals continue to recommend this dosage for initial tapering, the 2mg nicotine gum segment is well-positioned for growth within the market.

4mg Nicotine Gum:

The 4mg nicotine gum is targeted towards moderate to heavy smokers who are looking to quit smoking. This variant is particularly effective for individuals who smoke more than 25 cigarettes a day, delivering a stronger dose of nicotine to help manage cravings and withdrawal symptoms. The 4mg gum provides users with the necessary support to transition from smoking to complete cessation. This segment's growth is bolstered by increasing awareness among smokers about the benefits of nicotine replacement therapies in quitting smoking. Additionally, the appeal of the 4mg gum's effectiveness in alleviating cravings and the convenience of its use contribute to its rising popularity, making it a staple product in many quit-smoking programs.

6mg Nicotine Gum:

The 6mg nicotine gum segment is gaining traction among smokers who require a higher dosage to effectively combat their cravings. This strength is particularly appealing to individuals who find that lower doses are insufficient for their nicotine needs. The 6mg variant serves as a bridge for those who may have previously used higher-strength products or are struggling with withdrawal symptoms. This segment benefits from a growing trend toward personalized cessation strategies, as smokers increasingly seek solutions that cater to their specific requirements. The effectiveness of the 6mg gum in delivering nicotine while allowing users to gradually reduce their intake makes it a popular choice in the market for nicotine replacement therapies.

8mg Nicotine Gum:

The 8mg nicotine gum is an emerging player in the nicotine gum market, designed for a niche group of users who require a higher nicotine dose. This strength caters to heavy smokers who often experience intense cravings that lower doses cannot satisfy. The 8mg gum is particularly advantageous during critical moments when cravings peak, providing the necessary support to prevent relapse. Its inclusion in the market adds an important dimension to nicotine replacement therapy options, allowing users to find a product that best suits their smoking habits. Additionally, the availability of this gum in various flavors increases its appeal, encouraging compliance among users who may be hesitant to use traditional gums.

10mg Nicotine Gum:

The 10mg nicotine gum segment is relatively new but is gaining attention as it caters specifically to a very niche demographic of heavy smokers who require substantial nicotine replacement. The higher dosage is designed to assist users in overcoming severe cravings and withdrawal symptoms that arise when attempting to quit smoking. This product is crucial for those who have previously struggled with lower dosages and found them ineffective. The market for 10mg gum is expected to experience growth as more consumers become aware of its availability and efficacy. With ongoing research into the needs of smokers and their cessation journeys, the 10mg nicotine gum is positioned to emerge as a viable option for those in need of a higher nicotine intake.

By Application

Smoking Cessation:

The smoking cessation application is the primary driving force behind the nicotine gum market. Nicotine gum is widely recognized as an effective tool for individuals attempting to quit smoking, helping to alleviate withdrawal symptoms and cravings associated with nicotine addiction. This segment's growth is supported by extensive clinical research demonstrating the effectiveness of nicotine replacement therapy in improving cessation rates. Various health organizations and governments actively promote nicotine gum as part of comprehensive smoking cessation programs, further driving consumer adoption. As more smokers seek reliable solutions to quit, the smoking cessation application continues to dominate the nicotine gum market, establishing a significant share of overall sales.

Nicotine Replacement Therapy:

Within the nicotine gum market, the nicotine replacement therapy (NRT) application is an essential segment aimed at helping users manage their nicotine cravings effectively. NRT strategies encompass a range of products, including nicotine patches, lozenges, and gums, with the latter being particularly favored for its flexibility and immediate effects. Nicotine gum allows users to control their nicotine intake actively, making it especially appealing to those who prefer a more hands-on approach to managing cravings. The integration of nicotine gum into broader NRT programs ensures that users have access to diverse options tailored to their needs, thereby enhancing the overall effectiveness of smoking cessation efforts.

By Distribution Channel

Pharmacies:

Pharmacies remain one of the most significant distribution channels for nicotine gum, providing consumers with easy access to smoking cessation products. This channel is preferred due to the ability for customers to seek advice and recommendations from pharmacists, who can guide them toward the most appropriate product for their specific needs. Pharmacies typically carry a wide range of nicotine gum options, including various strengths and flavors, ensuring that consumers have ample choices to select from. The visibility of nicotine gum in pharmacies, often displayed in prominent locations, facilitates impulse buying among smokers looking to quit. Furthermore, the convenience and trust associated with pharmacies contribute to their strong position in the distribution landscape of nicotine gums.

Online Retail:

The online retail segment for nicotine gum is experiencing rapid growth, driven largely by the increasing reliance on e-commerce for purchasing consumer goods. The convenience of shopping from home, coupled with the ability to compare prices and product offerings across multiple platforms, has made online retail an attractive option for consumers seeking nicotine gum. Online platforms often provide detailed product descriptions, customer reviews, and promotional discounts, enhancing the overall shopping experience. Additionally, the discreet nature of online purchases appeals to many smokers who may feel embarrassed buying cessation products in-person. This channel's growth is expected to continue as more retailers invest in their online presence to cater to changing consumer preferences.

Convenience Stores:

Convenience stores are another crucial distribution channel for nicotine gum, offering consumers a quick and easy option for purchasing smoking cessation products. These stores typically have extended operating hours and are strategically located in high-traffic areas, making them an accessible choice for consumers in need of immediate solutions. The availability of nicotine gum alongside other everyday products encourages impulse buying, particularly among smokers who may encounter a craving unexpectedly. Many convenience stores are also stocking a broader range of nicotine gum products, including various flavors and dosages, to cater to the diverse preferences of consumers. As the demand for on-the-go solutions rises, the importance of convenience stores in the nicotine gum market remains significant.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets play a vital role in the nicotine gum distribution network, providing consumers with a comprehensive selection of smoking cessation products. These larger retail outlets typically feature dedicated health and wellness sections, where nicotine gum is prominently displayed alongside other cessation aids. The extensive range of products available allows consumers to choose from various strengths and flavors, catering to their unique tastes and preferences. Additionally, the competitive pricing often found in supermarkets and hypermarkets can be attractive to consumers looking for value, which may further boost sales. The convenience of one-stop shopping for groceries and health products encourages consumers to purchase nicotine gum, solidifying this channel's relevance in the market.

By Ingredient Type

Mint Flavor:

Mint flavor is among the most popular options in the nicotine gum market, appealing to many consumers due to its refreshing taste. The cool, crisp flavor of mint not only masks the bitterness of nicotine but also provides an invigorating sensation that is often associated with oral satisfaction. Mint-flavored gum is frequently recommended for new users, as its familiarity makes the transition away from smoking more comfortable. Additionally, the broad appeal of mint flavor means it is commonly stocked across various retail channels, enhancing its accessibility. The popularity of mint-flavored nicotine gum continues to support its significant share of the overall market.

Fruit Flavor:

Fruit-flavored nicotine gum is gaining traction among consumers looking for variety and a more enjoyable chewing experience. The sweetness and familiar tastes of fruit flavors can help to make the process of quitting smoking less daunting. Flavors such as cherry, strawberry, and citrus not only appeal to a younger demographic but also cater to those seeking alternatives to traditional mint options. This diverse range of fruit flavors makes nicotine gum more palatable and encourages adherence to cessation efforts, as consumers are more likely to choose a product that aligns with their taste preferences. The growth of fruit-flavored options supports the expanding nicotine gum market.

Herbal Flavor:

Herbal-flavored nicotine gum offers a unique alternative for consumers who prefer natural tastes over the more conventional mint and fruit options. This flavor category is particularly appealing to health-conscious individuals who may be wary of artificial additives and sweeteners. Herbal flavors, such as green tea or ginger, leverage the growing trend toward herbal and organic products, positioning them favorably within the market. As consumer preferences evolve to include more diverse and unique flavor profiles, herbal-flavored nicotine gum is expected to capture a growing share of the market, catering to a niche but dedicated consumer base.

Spice Flavor:

Spice-flavored nicotine gum is a lesser-known but emerging category in the nicotine gum market. Flavors such as cinnamon or clove provide an interesting twist for consumers looking for something different from the more traditional choices. This flavor adds an element of warmth and complexity that can enhance the chewing experience. As the market shifts towards more diverse flavor offerings, spice flavors are carving out a niche for themselves, attracting adventurous consumers who wish to explore unique tastes while managing their nicotine cravings. The novelty of spice flavors can also contribute to brand differentiation, encouraging manufacturers to innovate and expand their offerings.

Chocolate Flavor:

Chocolate flavor in nicotine gum is a relatively novel concept that appeals particularly to those with a sweet tooth. The indulgent taste of chocolate can serve as a comforting alternative for smokers seeking to satisfy their cravings in a more enjoyable manner. This flavor's sweetness can mask the unpleasant taste of nicotine, making it more palatable for certain consumers. Furthermore, chocolate-flavored nicotine gum introduces an element of pleasure into the quitting process, which can enhance the overall experience and promote adherence to cessation efforts. As consumer preferences continue to evolve, chocolate-flavored nicotine gum is expected to gain traction, contributing positively to market growth.

By Region

The North American region is currently the largest market for nicotine gum, accounting for approximately 40% of the global market share. The prevalence of smoking, combined with robust public health initiatives aimed at reducing tobacco use, has led to increased adoption of nicotine replacement therapies. The United States, in particular, has seen significant growth in nicotine gum sales, fueled by a strong consumer awareness of smoking cessation options and the availability of various product types. With a projected CAGR of 6.5% during the forecast period, North America is expected to maintain its dominance, as both prescription and over-the-counter nicotine replacement products become increasingly integrated into broader healthcare initiatives.

Europe follows closely behind North America, contributing roughly 30% to the global nicotine gum market. The European market benefits from stringent tobacco control policies and widespread health campaigns targeting smoking cessation. Countries such as the United Kingdom and Germany lead in market growth due to their proactive approaches to combat tobacco use, promoting the use of nicotine gum as an effective cessation method. As European consumers become more health-conscious and seek alternatives to smoking, the nicotine gum segment is expected to continue its upward trajectory, with an anticipated CAGR of 5.8% over the forecast period. The growing acceptance of flavored options and increasing availability in retail channels are additional factors contributing to the region's market growth.

Opportunities

The nicotine gum market is poised for significant opportunities in the coming years as the global push toward smoking cessation continues to gain momentum. One of the most promising opportunities lies in the development of innovative formulations that cater to diverse consumer preferences. This includes further exploration of unique flavors and ingredient types that resonate with health-conscious consumers. The introduction of sugar-free options and organic ingredients can appeal to a more extensive demographic, particularly among younger consumers who prioritize wellness. Additionally, leveraging digital platforms for marketing and sales can enhance the reach of nicotine gum products, tapping into the growing trend of online shopping. This strategic marketing approach can also involve partnerships with health organizations and influencers to raise awareness and credibility around nicotine replacement therapies.

Furthermore, the expansion into emerging markets presents another significant opportunity for growth in the nicotine gum sector. Countries in Asia Pacific and Latin America exhibit increasing smoking rates, combined with a rising awareness of the health risks associated with tobacco use. As local populations become more receptive to cessation products, the introduction of nicotine gum and other alternatives can fill a critical gap in the market. Tailoring marketing strategies to align with cultural nuances and preferences within these regions will be essential for success. Establishing local partnerships with pharmacies and health institutions can further facilitate market penetration, ensuring that nicotine gum becomes a recognized and trusted option for individuals seeking to quit smoking.

Threats

Despite the positive outlook for the nicotine gum market, several threats could impede its growth. One of the primary threats is the intense competition posed by alternative nicotine replacement therapies, such as patches, lozenges, and inhalers. These alternatives often compete on efficacy, convenience, and price, leading consumers to opt for what they perceive as more effective or easier-to-use solutions. Additionally, the increasing popularity of vaping among smokers seeking alternatives to traditional tobacco products poses a significant challenge. As vaping devices and e-liquids gain traction, they divert potential consumers away from nicotine gums, impacting overall sales. The perception that vaping is a safer option might also deter smokers from considering nicotine gum as a viable method for cessation.

Another significant concern is potential regulatory changes affecting nicotine products. Governments worldwide are increasingly scrutinizing nicotine-containing products, leading to the implementation of stricter regulations regarding marketing, packaging, and sales. This shift can pose challenges to manufacturers who may need to adjust their strategies to comply with evolving laws. Moreover, negative public perceptions surrounding nicotine products, including concerns about addiction and health risks, could hinder consumer willingness to try nicotine gum. Addressing these perceptions through education and awareness campaigns will be crucial in mitigating these threats and encouraging broader acceptance of nicotine gum as a legitimate cessation tool.

Competitor Outlook

• Reynolds American Inc.
• Philip Morris International Inc.
• GlaxoSmithKline plc
• Johnson & Johnson Consumer Inc.
• Pfizer Inc.
• Novartis AG
• CB Therapeutics
• Medichem
• Haleon
• Bristol-Myers Squibb Company
• Chantix
• Nicorette
• Nicorette Mini
• Equate
• Stop Smoking Aid

The competitive landscape of the nicotine gum market is characterized by a diverse range of players, including pharmaceutical giants and specialized manufacturers focusing on smoking cessation products. Key players like Reynolds American Inc. and Philip Morris International Inc. have established a strong presence by leveraging their extensive distribution networks and brand recognition. These companies often invest in research and development to innovate their product lines, ensuring they meet the evolving needs of consumers. The competition is not only about product differentiation, but also encompasses marketing strategies, pricing, and promotional campaigns aimed at capturing the attention of potential users seeking to quit smoking.

GlaxoSmithKline, one of the leading players in the market, has been pivotal in shaping the nicotine gum landscape. Their Nicorette brand is synonymous with nicotine replacement therapy and continues to dominate sales. The company's commitment to scientific research and its focus on creating a variety of flavors and strengths have allowed it to maintain a competitive edge. Furthermore, GSK actively engages in public health initiatives aimed at promoting smoking cessation, which reinforces its position as a leader in the market. This dedication to not only selling products but also supporting health initiatives makes GSK a formidable competitor.

Johnson & Johnson Consumer Inc. is another key player, leveraging its expertise in health and wellness products to capture a significant share of the nicotine gum market. The company emphasizes creating accessible and effective solutions, such as their Nicorette brand, which caters to diverse consumer preferences. Their marketing strategy often includes collaboration with healthcare professionals to enhance trust and credibility among consumers. Johnson & Johnson is also known for its innovative approaches, including the development of sugar-free variations of nicotine gum to align with health-conscious consumer trends.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Equate
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Haleon
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Chantix
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medichem
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Nicorette
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Novartis AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Pfizer Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Nicorette Mini
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 CB Therapeutics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stop Smoking Aid
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 GlaxoSmithKline plc
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Reynolds American Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bristol-Myers Squibb Company
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Johnson & Johnson Consumer Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Philip Morris International Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Nicotine Gum Sales Market, By Application
    • 6.1.1 Smoking Cessation
    • 6.1.2 Nicotine Replacement Therapy
  • 6.2 Nicotine Gum Sales Market, By Product Type
    • 6.2.1 2mg Nicotine Gum
    • 6.2.2 4mg Nicotine Gum
    • 6.2.3 6mg Nicotine Gum
    • 6.2.4 8mg Nicotine Gum
    • 6.2.5 10mg Nicotine Gum
  • 6.3 Nicotine Gum Sales Market, By Ingredient Type
    • 6.3.1 Mint Flavor
    • 6.3.2 Fruit Flavor
    • 6.3.3 Herbal Flavor
    • 6.3.4 Spice Flavor
    • 6.3.5 Chocolate Flavor
  • 6.4 Nicotine Gum Sales Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Retail
    • 6.4.3 Convenience Stores
    • 6.4.4 Supermarkets/Hypermarkets

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Nicotine Gum Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nicotine Gum Sales market is categorized based on

By Product Type

• 2mg Nicotine Gum
• 4mg Nicotine Gum
• 6mg Nicotine Gum
• 8mg Nicotine Gum
• 10mg Nicotine Gum

By Application

• Smoking Cessation
• Nicotine Replacement Therapy

By Distribution Channel

• Pharmacies
• Online Retail
• Convenience Stores
• Supermarkets/Hypermarkets

By Ingredient Type

• Mint Flavor
• Fruit Flavor
• Herbal Flavor
• Spice Flavor
• Chocolate Flavor

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Reynolds American Inc.
• Philip Morris International Inc.
• GlaxoSmithKline plc
• Johnson & Johnson Consumer Inc.
• Pfizer Inc.
• Novartis AG
• CB Therapeutics
• Medichem
• Haleon
• Bristol-Myers Squibb Company
• Chantix
• Nicorette
• Nicorette Mini
• Equate
• Stop Smoking Aid